IL121165A0
(en)
*
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
US6180671B1
(en)
|
1998-03-10 |
2001-01-30 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
|
DE19836339B4
(de)
|
1998-08-11 |
2011-12-22 |
N.V. Nutricia |
Kohlenhydratmischung
|
US20090274660A1
(en)
*
|
1999-08-17 |
2009-11-05 |
Immunopath Profile, Inc. |
Pluripotent therapeutic compositions and uses thereof
|
US6495599B2
(en)
*
|
2000-04-13 |
2002-12-17 |
Abbott Laboratories |
Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
|
WO2004028529A1
(en)
*
|
2002-09-24 |
2004-04-08 |
Suntory Limited |
Composition with effects of decline prevention, improvement or enhancement of normal responses of cognitive abilities of a healthy person
|
US7323206B1
(en)
|
2003-03-04 |
2008-01-29 |
B. Braun Medical Inc. |
Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
WO2004112507A1
(en)
*
|
2003-06-23 |
2004-12-29 |
Nestec S.A. |
Infant or follow-on formula
|
CA2530170A1
(en)
*
|
2003-06-24 |
2005-01-06 |
University Of Kansas Medical Center |
Infant formula
|
GB2422373B
(en)
*
|
2003-08-18 |
2008-05-21 |
Btg Int Ltd |
Treatment of neurodegenerative conditions
|
EP1597978A1
(de)
|
2004-05-17 |
2005-11-23 |
Nutricia N.V. |
Synergie von GOS und polyfruktose
|
US8252769B2
(en)
|
2004-06-22 |
2012-08-28 |
N. V. Nutricia |
Intestinal barrier integrity
|
NZ552118A
(en)
*
|
2004-06-22 |
2010-03-26 |
Nutricia Nv |
Improvement of barrier integrity in HIV patients with fatty acids
|
EP1721611A1
(de)
*
|
2005-04-21 |
2006-11-15 |
N.V. Nutricia |
Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
|
US7862808B2
(en)
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
EP1656839A1
(de)
*
|
2004-11-11 |
2006-05-17 |
N.V. Nutricia |
Nahrung, die eine Lipidmischung enthält
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
US20060233762A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Mcmahon Robert J |
Method for treating or preventing systemic inflammation in formula-fed infants
|
US7303745B2
(en)
|
2005-04-15 |
2007-12-04 |
Bristol-Myers Squibb Company |
Method for preventing or treating the development of respiratory allergies
|
EP1871181B2
(de)
*
|
2005-04-21 |
2016-12-21 |
N.V. Nutricia |
Nahrungsergänzungsmittel für hiv-patienten
|
ES2615521T3
(es)
|
2005-05-23 |
2017-06-07 |
Massachusetts Institute Of Technology |
Composiciones que contienen PUFA y métodos de uso de las mismas
|
JP2007063219A
(ja)
*
|
2005-09-01 |
2007-03-15 |
Juntendo |
新生児壊死性腸炎疾患予防剤
|
US20070166354A1
(en)
*
|
2005-10-26 |
2007-07-19 |
Bridget Barrett-Reis |
Method of reducing the risk of retinopathy of prematurity in preterm infants
|
US7829126B2
(en)
|
2005-10-26 |
2010-11-09 |
Abbott Laboratories |
Infant formulas containing docosahexaenoic acid and lutein
|
WO2007059431A1
(en)
*
|
2005-11-14 |
2007-05-24 |
The Trustees Of Columbia University In The City Of New York |
Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
|
RU2417712C2
(ru)
*
|
2005-12-23 |
2011-05-10 |
Н.В. Нютрисиа |
Питательная композиция для младенцев, предназначенная для предупреждения ожирения
|
US20080003329A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Ricardo Rueda |
Enriched infant formulas
|
US20080003330A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Ricardo Rueda |
Infant formulas for early brain development
|
US7867542B2
(en)
*
|
2006-11-02 |
2011-01-11 |
Ach Food Companies, Inc. |
Non-flammable release composition
|
EP2200443B2
(de)
|
2007-09-17 |
2021-06-30 |
Cornell University |
Verzweigtkettige fettsäuren für die vorbeugung oder behandlung von störungen des magen-darm-trakts
|
CN101896073B
(zh)
|
2007-10-09 |
2013-11-20 |
酶学技术有限公司 |
用于治疗胃肠道紊乱和促进肠道发育及成熟的脂质组合物
|
UY31410A1
(es)
*
|
2007-10-30 |
2009-05-29 |
|
Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
|
ES2660416T3
(es)
|
2007-11-01 |
2018-03-22 |
Enzymotec Ltd. |
Mezcla de lípidos para la nutrición de bebés
|
US8361534B2
(en)
*
|
2007-12-20 |
2013-01-29 |
Abbott Laboratories |
Stable nutritional powder
|
BRPI0820584A2
(pt)
*
|
2007-12-20 |
2015-07-14 |
Abbott Lab |
Pó nutricional estável
|
EP2100897A1
(de)
*
|
2008-01-30 |
2009-09-16 |
BNLfood Investments SARL |
Zusammensetzung auf Lecithinbasis und deren Verwendung in Nahrungsmitteln
|
WO2009096772A1
(en)
*
|
2008-02-01 |
2009-08-06 |
N.V. Nutricia |
Composition for stimulating natural killer cell activity
|
US9737213B1
(en)
*
|
2009-03-24 |
2017-08-22 |
Vioptix, Inc. |
Using an oximeter probe to detect intestinal ischemia
|
RU2559646C2
(ru)
*
|
2009-04-01 |
2015-08-10 |
Нестек С.А. |
Снижение риска ожирения
|
TW201112967A
(en)
*
|
2009-09-16 |
2011-04-16 |
Abbott Lab |
Dryblended nutritional powders
|
TW201121431A
(en)
|
2009-12-01 |
2011-07-01 |
Abbott Lab |
Soy protein-based nutritional formula with superior stability
|
TWI492744B
(zh)
|
2009-12-04 |
2015-07-21 |
Abbott Lab |
使用類胡蘿蔔素調節早產兒發炎症之方法
|
RU2563355C2
(ru)
*
|
2009-12-08 |
2015-09-20 |
Нестек С.А. |
Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока
|
WO2011090926A1
(en)
|
2010-01-19 |
2011-07-28 |
Abbott Laboratories |
Nutritional formulas containing synbiotics
|
ES2481865T3
(es)
|
2010-01-29 |
2014-07-31 |
Abbott Laboratories |
Emulsiones nutricionales que comprenden HMB de calcio
|
EP2461704B1
(de)
|
2010-01-29 |
2013-10-09 |
Abbott Laboratories |
Aseptisch verpackte nahrungsflüssigkeiten mit hmb
|
US9693577B2
(en)
|
2010-01-29 |
2017-07-04 |
Abbott Laboratories |
Method of preparing a nutritional powder comprising spray dried HMB
|
TWI526161B
(zh)
|
2010-06-10 |
2016-03-21 |
亞培公司 |
包含鈣hmb及可溶性蛋白質之實質上透明營養液
|
EP2397038A1
(de)
|
2010-06-21 |
2011-12-21 |
Abbott Laboratories |
Frühe Programmierung der Hirnfunktion durch Sojaproteinzufuhr
|
WO2012009426A1
(en)
|
2010-07-13 |
2012-01-19 |
Abbott Laboratories |
High tolerance infant formula including hydrolyzed protein
|
EP2422629A1
(de)
|
2010-08-23 |
2012-02-29 |
Abbott Laboratories |
Verfahren zur Verbesserung der Kognition/von Gedächtnis mit Hilfe von Maltodextrin
|
WO2012027287A1
(en)
|
2010-08-24 |
2012-03-01 |
Abbott Laboratories |
Nutritional products including pea protein hydrolysates
|
EP2984941A1
(de)
|
2010-08-24 |
2016-02-17 |
Abbott Laboratories |
Ernährungsprodukte mit verbesserten organoleptischen eigenschaften
|
CN103260440B
(zh)
|
2010-12-29 |
2017-03-29 |
雅培制药有限公司 |
包括含有甘油单酯的脂肪系统的营养型产品
|
US9763970B2
(en)
|
2010-12-31 |
2017-09-19 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
|
CN107019701B
(zh)
|
2010-12-31 |
2020-07-28 |
雅培制药有限公司 |
使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
|
US20120171166A1
(en)
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
|
EP2658549B1
(de)
|
2010-12-31 |
2020-06-03 |
Abbott Laboratories |
Verfahren zur reduzierung des auftretens von oxidativem stress unter verwendung von menschlichen milcholigosacchariden, vitamin c und entzündungshemmern
|
MY166945A
(en)
|
2010-12-31 |
2018-07-25 |
Abbott Lab |
Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
|
CN103391783A
(zh)
|
2010-12-31 |
2013-11-13 |
雅培制药有限公司 |
使用人乳寡糖改善呼吸道健康的方法
|
CN103402376A
(zh)
|
2010-12-31 |
2013-11-20 |
雅培制药有限公司 |
促进有益细菌生长的中性人乳寡糖
|
ES2825049T3
(es)
|
2010-12-31 |
2021-05-14 |
Abbott Lab |
Oligosacáridos de leche humana para modular inflamación
|
WO2013012989A2
(en)
|
2011-07-19 |
2013-01-24 |
The Trustees Of Columbia University In The City Of New York |
Method and system for production of hydrogen and carbon monoxide
|
ES2657744T3
(es)
|
2011-07-22 |
2018-03-06 |
Abbott Laboratories |
Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
|
CN113662199A
(zh)
|
2011-08-29 |
2021-11-19 |
雅培制药有限公司 |
用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
|
WO2013101516A1
(en)
|
2011-12-29 |
2013-07-04 |
Abbott Laboratories |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
|
US20140335259A1
(en)
|
2011-12-29 |
2014-11-13 |
Abbott Laboratories |
Methods for reducing microbial contamination of dryblended powdered nutritional compositions
|
SG11201406022YA
(en)
|
2012-03-27 |
2014-10-30 |
Abbott Lab |
Methods for modulating cell-mediated immunity using human milk oligosaccharides
|
WO2013170189A1
(en)
|
2012-05-11 |
2013-11-14 |
Abbott Laboratories |
Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
|
DK2708147T3
(da)
|
2012-09-14 |
2020-05-18 |
Abbott Lab |
Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
|
ES2572831T3
(es)
|
2012-09-14 |
2016-06-02 |
Abbott Laboratories |
Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
|
EP2708146A1
(de)
|
2012-09-17 |
2014-03-19 |
Abbott Laboratories, Inc. |
Ernährungszusammensetzung für schwangere Frauen mit einem förderlichen Glucose- und Insulinprofil
|
WO2014078544A1
(en)
|
2012-11-14 |
2014-05-22 |
Abbott Laboratories |
Compositions and methods for improving the long term safety of powdered infant formulas
|
WO2014099904A1
(en)
|
2012-12-17 |
2014-06-26 |
Abbott Laboratories |
Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
|
TW201438719A
(zh)
|
2012-12-18 |
2014-10-16 |
Abbott Lab |
改善壓力症狀之母乳寡糖
|
EP2745705A1
(de)
|
2012-12-18 |
2014-06-25 |
Abbott Laboratories |
Ernährungsbedingte Verwendung von Muttermilch Oligosacchariden
|
WO2014100022A1
(en)
|
2012-12-18 |
2014-06-26 |
Abbott Laboratories |
Dietary oligosaccharides to enhance learning and memory
|
EP3469912A1
(de)
|
2012-12-20 |
2019-04-17 |
Abbott Laboratories |
Nährstoffformulierungen mit verwendung von muttermilcholigosacchariden zur modulierung von entzündungen
|
EP2745708A1
(de)
|
2012-12-24 |
2014-06-25 |
Abbott Laboratories, Inc. |
Antidepressionswirkung von ß-Hydroxy-ß-Methylbutyrat
|
EP2983526A1
(de)
|
2013-03-12 |
2016-02-17 |
Abbott Laboratories |
Zusammensetzung mit einen multifunktionsviskositätsmodifikator
|
EP2986163B1
(de)
|
2013-03-15 |
2017-04-19 |
Abbott Laboratories |
Nahrungsmittelprodukte mit calcium beta-hydroxy-beta-methylbutyrat, caseinphosphopeptide und proteine
|
EP2986158A1
(de)
|
2013-03-15 |
2016-02-24 |
Abbott Laboratories |
Verfahren zur bewahrung und verbesserung der muskelfunktion
|
US10070643B2
(en)
|
2013-03-28 |
2018-09-11 |
The Trustees Of Columbia University In The City Of New York |
Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
|
US20160136192A1
(en)
|
2013-06-10 |
2016-05-19 |
Abbott Laboratories |
Methods and compositions for enhancing cognitive performance
|
WO2015048646A1
(en)
|
2013-09-30 |
2015-04-02 |
Abbott Laboratories |
Protein powder
|
IN2015DN03236A
(de)
|
2013-10-11 |
2015-10-02 |
Abbott Lab |
|
CN103558296B
(zh)
*
|
2013-10-18 |
2015-03-04 |
中国农业大学 |
一种基于脂肪酸检测的动物源性饲料原料鉴别方法
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
US10568896B2
(en)
|
2013-11-19 |
2020-02-25 |
Abbott Laboratories |
Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
|
EP2888950A1
(de)
|
2013-12-24 |
2015-07-01 |
Abbott Laboratories |
Verfahren zur Behandlung, Prävention oder Verringerung von Nervenentzündung oder kognitiver Beeinträchtigung
|
WO2015105981A2
(en)
|
2014-01-09 |
2015-07-16 |
Abbott Laboratories |
Conditional essentiality of hmb
|
CN113331426A
(zh)
|
2014-04-08 |
2021-09-03 |
雅培公司 |
使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
|
DE102015101273A1
(de)
|
2015-01-29 |
2016-08-04 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Prophylaxe und Behandlung von frühgeburtlichkeitsassoziierten Entwicklungsstörungen
|
US11510966B2
(en)
|
2016-04-15 |
2022-11-29 |
Evive Biotechnology (Shanghai) Ltd |
Use of IL-22 in treating necrotizing enterocolitis
|
RU2665947C1
(ru)
*
|
2017-07-13 |
2018-09-05 |
Атикат Магомедхановна Герейханова |
Способ лечения некротического энтероколита
|
US20220312814A1
(en)
|
2019-06-07 |
2022-10-06 |
Abbott Laboratories |
Nutritional ingredient with flow and antifoam properties
|
US20230149542A1
(en)
|
2020-04-06 |
2023-05-18 |
Abbott Laboratories |
Nutritional formulations for modulating respiratory-induced cytokines
|
CN112137998A
(zh)
*
|
2020-10-10 |
2020-12-29 |
上海交通大学医学院附属新华医院 |
一种活性成分在制备防治坏死性小肠结肠炎药物中的应用
|
WO2022177965A1
(en)
|
2021-02-16 |
2022-08-25 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
|
WO2022226311A1
(en)
|
2021-04-23 |
2022-10-27 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function
|
WO2022266058A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods and compositions for treating gas
|
WO2023159093A1
(en)
|
2022-02-16 |
2023-08-24 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
|
WO2024064327A1
(en)
|
2022-09-22 |
2024-03-28 |
Abbott Laboratories |
Human milk oligosaccharides for enhancing blood-brain barrier function
|